Figure S1 from ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity
XiaoPeng Wang, Mo Zhu, Hao Zuo, Guowei Hou, Rui Xie
Abstract
XiaoPeng Wang, Mo Zhu, Hao Zuo, Guowei Hou, Rui Xie
Abstract
Figure S1. The correlation analysis between ADAM12 and YAP1. (A) The correlation analysis between ADAM12 and YAP1 in CRC based on the TCGA-COAD data. (B) The correlation analysis between ADAM12 and YAP1 in CRC patients. (C) CRC patients with high YAP1 expression showed markedly lower 2000-days survival than those with low YAP1 expression. (D) Western blot analysis of ADAM12 in T84 cells with YAP1 knockdown.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Figure S1. The correlation analysis between ADAM12 and YAP1. (A) The correlation analysis between ADAM12 and YAP1 in CRC based on the TCGA-COAD data. (B) The correlation analysis between ADAM12 and YAP1 in CRC patients. (C) CRC patients with high YAP1 expression showed markedly lower 2000-days survival than those with low YAP1 expression. (D) Western blot analysis of ADAM12 in T84 cells with YAP1 knockdown.
Key concepts: YAP1, Hippo signaling pathway, Gene knockdown, Colorectal cancer, Western blot, Cancer research, Medicine, Oncology